Journal Sections

Covers preclinical and clinical pharmacology of oncologic agents including targeted therapies, immunotherapies, antibody-drug conjugates, and combination regimens. Focus on pharmacokinetics, pharmacodynamics, drug resistance, and CNS penetration.

Research on lymphomas, leukemias, myelomas, and related disorders. Encompasses diagnosis, staging, treatment response assessment, minimal residual disease, and transplant approaches in hematologic cancers.

Dedicated to primary and secondary CNS malignancies, including CNS lymphoma, brain metastases, gliomas, and leptomeningeal disease. Special focus on BBB penetration strategies and intrathecal therapies.

Covers checkpoint inhibitors, monoclonal antibodies, bispecific T-cell engagers, ADCs, and cellular immunotherapies in oncology. Includes mechanistic studies, clinical outcomes, and resistance mechanisms.

Radiotherapy techniques, dose fractionation, radiation biology, and combination with systemic therapies. Includes IMRT, stereotactic radiosurgery, and whole-brain radiation in lymphoma and CNS malignancies.

Bench-to-bedside research translating basic science discoveries into clinical applications. Biomarker development, genomics, proteomics, and molecular pathology in cancer diagnosis and treatment.